nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—TOP2A—Irinotecan—Topotecan—cervical cancer	0.221	1	CbGdCrCtD
Valrubicin—TOP2A—uterine cervix—cervical cancer	0.123	0.157	CbGeAlD
Valrubicin—TOP2A—decidua—cervical cancer	0.117	0.15	CbGeAlD
Valrubicin—TOP2A—endometrium—cervical cancer	0.111	0.142	CbGeAlD
Valrubicin—TOP2A—mammalian vulva—cervical cancer	0.107	0.138	CbGeAlD
Valrubicin—TOP2A—uterus—cervical cancer	0.102	0.131	CbGeAlD
Valrubicin—TOP2A—female gonad—cervical cancer	0.0835	0.107	CbGeAlD
Valrubicin—TOP2A—vagina—cervical cancer	0.083	0.107	CbGeAlD
Valrubicin—TOP2A—lymph node—cervical cancer	0.0537	0.0689	CbGeAlD
